lung cancer

2017 ASCO Annual Meeting. #ASCO17
June 3, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing. Read More >>
2017 ASCO Annual Meeting. #ASCO17
May 17, 2017 · Monika Joshi, ASCO staff
Read highlighted cancer research that will be presented at the 2017 ASCO Annual Meeting, where oncology professionals from around the globe will gather in Chicago in June. Read More >>
April 6, 2017 · Nathan A. Pennell, MD, PhD
The Multidisciplinary Thoracic Cancers Symposium brings oncology professionals together to discuss ways to best treat people with lung cancer and other thoracic cancers. Dr. Nathan Pennell describes some of the research presented on targeted therapy, radiation therapy, and health disparities. Read More >>
November 8, 2016 · Jyoti Patel, MD, FASCO
Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month. Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 6, 2016 · Greg Guthrie, ASCO staff
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Some of those advances focus on improving the quality of care and patients’ access to it. Read More >>

Pages